Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Shares Issued (2016 - 2025)

Sunshine Biopharma's Shares Issued history spans 10 years, with the latest figure at $724500.0 for Q4 2025.

  • For Q4 2025, Shares Issued fell 55.23% year-over-year to $724500.0; the TTM value through Dec 2025 reached $19.8 million, up 455.11%, while the annual FY2025 figure was $2.9 million, 65.74% down from the prior year.
  • Shares Issued reached $724500.0 in Q4 2025 per SBFM's latest filing, down from $17.4 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $17.4 million in Q2 2025 to a low of -$14.4 million in Q2 2022.
  • Average Shares Issued over 4 years is $4.8 million, with a median of $5.2 million recorded in 2024.
  • The largest YoY upside for Shares Issued was 18956000.0% in 2024 against a maximum downside of 164.25% in 2024.
  • A 4-year view of Shares Issued shows it stood at $13.2 million in 2022, then crashed by 30.99% to $9.1 million in 2023, then plummeted by 82.23% to $1.6 million in 2024, then crashed by 55.23% to $724500.0 in 2025.
  • Per Business Quant, the three most recent readings for SBFM's Shares Issued are $724500.0 (Q4 2025), $17.4 million (Q2 2025), and $1.6 million (Q4 2024).